Skip to content

Face-to-Face Vs. Telerehabilitation for Thoracic Hyperkyphosis in Children: a Clinical Trial

Comparative Efficacy of Face-to-Face and Telerehabilitation Approaches in Managing Thoracic Hyperkyphosis Among 9-12-Year-Olds: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06730269
Enrollment
20
Registered
2024-12-12
Start date
2023-10-01
Completion date
2023-12-02
Last updated
2024-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperkyphosis, Kyphosis Thoracic

Keywords

Thoracic hyperkyphosis, face-to-face rehabilitation, telerehabilitation, spinal posture, musculoskeletal health, corrective exercises, Pediatric Kyphosis

Brief summary

This study evaluates the effectiveness of face-to-face versus telerehabilitation programs for children aged 9-12 with thoracic hyperkyphosis, a condition caused by poor posture that leads to excessive forward curvature of the spine. Twenty children participated in a six-week corrective exercise program, either in person or through an online platform. Both approaches significantly improved spinal posture, back muscle strength, and pain levels, with no notable differences in outcomes between the two methods. The findings suggest that telerehabilitation is as effective as face-to-face rehabilitation, offering a flexible option for managing thoracic hyperkyphosis in children.

Interventions

The Face-to-Face Rehabilitation Program is a structured rehabilitation regimen designed to improve posture, reduce pain, and strengthen back extensor muscles in children with thoracic hyperkyphosis. Participants in this group engaged in the Thoracic Corrective Exercise Program, which included four specific exercises targeting thoracic spine correction. The exercises were performed three times per week over six weeks, under the direct supervision of a trained therapist. This setup ensured real-time feedback, personalized adjustments, and guidance during each session, optimizing the effectiveness of the rehabilitation process.

The Telerehabilitation Program is a structured rehabilitation regimen designed to improve posture, reduce pain, and strengthen back extensor muscles in children with thoracic hyperkyphosis. Participants in this group followed the Thoracic Corrective Exercise Program, which included four specific exercises targeting thoracic spine correction, performed three times per week over six weeks. The program was delivered remotely through the Fiziu platform, allowing therapists to provide virtual guidance, feedback, and monitoring during the sessions. This approach offered flexibility for families and ensured accessibility to rehabilitation services from the comfort of their homes.

Sponsors

Medipol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 9-12 years. * Diagnosed with thoracic hyperkyphosis (Thoracic Kyphosis Angle \> 40 degrees). * Able to participate in a 6-week rehabilitation program (face-to-face or telerehabilitation).

Exclusion criteria

* Children with congenital spinal malformations. * Children with mental health issues that could interfere with participation or compliance in the study.

Design outcomes

Primary

MeasureTime frameDescription
Thoracic Kyphosis Angle (TKA)6 weeksIt was measured using a flexicurve ruler to assess the curvature of the thoracic spine before and after the intervention. \>45° is considered hyperkyphosis
Manual Muscle Test (MMT)6 weeksEvaluates back muscle strength before and after the intervention. Minimum = 0 (no muscle contraction), Maximum = 5 (normal muscle strength).
Visual Analog Scale (VAS)6 weeksAssesses pain levels before and after the intervention. Minimum = 0 (no pain), Maximum = 10 (worst possible pain)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026